Literature DB >> 16946823

BALANCE: a large simple trial of maintenance treatment for bipolar disorder.

John R Geddes1, Jennifer M Rendell, Guy M Goodwin.   

Abstract

Entities:  

Year:  2002        PMID： 16946823      PMCID： PMC1489827     

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  22 in total

1.  Attitudes of patients to randomised clinical trials of cancer therapy.

Authors:  L J Fallowfield; V Jenkins; C Brennan; M Sawtell; C Moynihan; R L Souhami
Journal:  Eur J Cancer       Date:  1998-09       Impact factor: 9.162

2.  Use of mood stabilizers by hospitalized geriatric patients with bipolar disorder.

Authors:  D R Sanderson
Journal:  Psychiatr Serv       Date:  1998-09       Impact factor: 3.084

Review 3.  Lithium: a molecular transducer of mood-stabilization in the treatment of bipolar disorder.

Authors:  H K Manji; R H Lenox
Journal:  Neuropsychopharmacology       Date:  1998-09       Impact factor: 7.853

4.  A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group.

Authors:  C L Bowden; J R Calabrese; S L McElroy; L Gyulai; A Wassef; F Petty; H G Pope; J C Chou; P E Keck; L J Rhodes; A C Swann; R M Hirschfeld; P J Wozniak
Journal:  Arch Gen Psychiatry       Date:  2000-05

5.  Strategic physician communication and oncology clinical trials.

Authors:  T L Albrecht; C Blanchard; J C Ruckdeschel; M Coovert; R Strongbow
Journal:  J Clin Oncol       Date:  1999-10       Impact factor: 44.544

Review 6.  Barriers to participation in randomised controlled trials: a systematic review.

Authors:  S Ross; A Grant; C Counsell; W Gillespie; I Russell; R Prescott
Journal:  J Clin Epidemiol       Date:  1999-12       Impact factor: 6.437

7.  Lithium versus carbamazepine in the maintenance treatment of bipolar disorders--a randomised study.

Authors:  W Greil; W Ludwig-Mayerhofer; N Erazo; C Schöchlin; S Schmidt; R R Engel; A Czernik; H Giedke; B Müller-Oerlinghausen; M Osterheider; G A Rudolf; H Sauer; J Tegeler; T Wetterling
Journal:  J Affect Disord       Date:  1997-04       Impact factor: 4.839

8.  Run-in periods in randomized trials: implications for the application of results in clinical practice.

Authors:  A Pablos-Méndez; R G Barr; S Shea
Journal:  JAMA       Date:  1998-01-21       Impact factor: 56.272

Review 9.  Risk of recurrence following discontinuation of lithium treatment in bipolar disorder.

Authors:  T Suppes; R J Baldessarini; G L Faedda; M Tohen
Journal:  Arch Gen Psychiatry       Date:  1991-12

10.  Relation of serum valproate concentration to response in mania.

Authors:  C L Bowden; P G Janicak; P Orsulak; A C Swann; J M Davis; J R Calabrese; P Goodnick; J G Small; A J Rush; S E Kimmel; S C Risch; D D Morris
Journal:  Am J Psychiatry       Date:  1996-06       Impact factor: 18.112
View more
  3 in total

1.  New trial should clarify lithium use in bipolar disorder.

Authors:  John Geddes; Guy Goodwin; Jennifer Rendell; Jane Hainsworth; Emma Van der Gucht; Heather Young
Journal:  BMJ       Date:  2002-08-24

2.  The CINP Guidelines on the Definition and Evidence-Based Interventions for Treatment-Resistant Bipolar Disorder.

Authors:  Konstantinos N Fountoulakis; Lakshmi N Yatham; Heinz Grunze; Eduard Vieta; Allan H Young; Pierre Blier; Mauricio Tohen; Siegfried Kasper; Hans Jurgen Moeller
Journal:  Int J Neuropsychopharmacol       Date:  2020-04-23       Impact factor: 5.176

3.  A randomized controlled trial comparing lithium plus valproic acid versus lithium plus carbamazepine in young patients with type 1 bipolar disorder: the LICAVAL study.

Authors:  Giovani Missio; Doris Hupfeld Moreno; Frederico Navas Demetrio; Marcio Gerhardt Soeiro-de-Souza; Fernando Dos Santos Fernandes; Vivian Boschesi Barros; Ricardo Alberto Moreno
Journal:  Trials       Date:  2019-10-26       Impact factor: 2.279
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.